Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Morgan Stanley slashed the price target for Intellia Therapeutics, Inc. NTLA from $56 to $11. Morgan Stanley analyst Terence Flynn downgraded the stock from Overweight to Equal-Weight. Intellia Therapeutics shares closed at $10.99 on Friday. See how other analysts view this stock.
  • Barclays cut McCormick & Company, Incorporated MKC price target from $85 to $82. Barclays analyst Andrew Lazar maintained an Equal-Weight rating. McCormick shares closed at $74.89 on Friday. See how other analysts view this stock.
  • Barclays raised the price target for Abbott Laboratories ABT from $149 to $158. Barclays analyst Matt Miksic maintained an Overweight rating. Abbott shares closed at $125.03 on Friday. See how other analysts view this stock.
  • Goldman Sachs raised the price target for Twilio Inc. TWLO from $77 to $185. Goldman Sachs analyst Kash Rangan upgraded the stock from Neutral to Buy. Twilio shares closed at $136.23 on Friday. See how other analysts view this stock.
  • Jefferies cut RLI Corp. RLI price target from $95 to $61. Jefferies analyst Andrew Andersen downgraded the stock from Buy to Underperform. RLI shares settled at $72.48 on Friday. See how other analysts view this stock.
  • Morgan Stanley raised Exelixis, Inc. EXEL price target from $30 to $40. Morgan Stanley analyst Jefferson Harralson upgraded the stock from Equal-Weight to Overweight. Exelixis shares closed at $32.38 on Friday. See how other analysts view this stock.
  • JP Morgan decreased Omnicom Group Inc. OMC price target from $119 to $116. JP Morgan analyst David Karnovsky maintained an Overweight rating. Omnicom shares closed at $86.56 on Friday.  See how other analysts view this stock.
  • Stifel raised the price target for Portillo’s Inc. PTLO from $13 to $16. Stifel analyst Chris O’Cull upgraded the stock from Hold to Buy. Portillo’s shares settled at $12.49 on Friday. See how other analysts view this stock.
  • Barclays cut RingCentral, Inc. RNG price target from $45 to $37. Barclays analyst Ryan Macwilliams downgraded the stock from Overweight to Equal-Weight. RingCentral shares closed at $34.65 on Friday. See how other analysts view this stock.
  • Piper Sandler increased Qorvo, Inc. QRVO price target from $85 to $110. Piper Sandler analyst Harsh Kumar upgraded the stock from Neutral to Overweight. Qorvo shares closed at $88.94 on Friday. See how other analysts view this stock.

Read This Next:

Got Questions? Ask
Which analysts could influence Abbott stock?
How will Abbott Laboratories respond to the price target change?
Which healthcare companies may follow Abbott's lead?
Could Intellia Therapeutics rebound from its downgrade?
What does McCormick's downgrade mean for competitors?
How might Twilio leverage its upgraded status?
What investment strategies benefit from Exelixis’s upgrade?
Will Omnicom face challenges post-downgrade?
Which restaurants could benefit from Portillo's upgrade?
How does Qorvo's upgrade affect tech investments?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: